Adipose ABCG1: A potential therapeutic target in obesity?
Related Experiment Video
Updated: Apr 1, 2026
Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Eric Frisdal1, Wilfried Le Goff1
1INSERM; UMR_S1166; Team 4 ; Paris, France ; Université Pierre et Marie Curie-Paris6 ; Paris, France ; Institute of Cardiometabolism and Nutrition (ICAN); Pitié-Salpêtrière Hospital ; Paris, France.
Abstract:
The importance of ATP-Binding Cassette G1 (ABCG1) transporter in obesity was recently brought to light by recent findings uncovering its key role in adipogenesis with physiopathological consequences in human obesity. Thus, silencing of ABCG1 expression using an RNAi approach allows inhibition of adipocyte differentiation and maturation leading to reduction of fat mass growth in vivo in mice. Studies of ABCG1 in obese subjects validated its deleterious role in the context of obesity, suggesting that adipose tissue ABCG1 could be a potential therapeutic target in obese patients. Here, we discuss the potential feasibility of such strategy and provide a brief overview of critical issues to be considered.
Insights
ATP-Binding Cassette G1 (ABCG1) transporter is crucial in obesity. Silencing ABCG1 inhibits fat cell development, reducing fat mass and suggesting ABCG1 as a therapeutic target for obesity.
Area of Science:
- Biochemistry
- Molecular Biology
- Metabolic Diseases
Background:
- ATP-Binding Cassette G1 (ABCG1) transporter plays a significant role in lipid metabolism.
- Recent findings highlight ABCG1's involvement in adipogenesis and its link to human obesity.
Purpose of the Study:
- To investigate the role of ABCG1 in adipogenesis and obesity.
- To evaluate the potential of targeting ABCG1 as a therapeutic strategy for obesity.
Main Methods:
- Utilized RNA interference (RNAi) to silence ABCG1 expression.
- Assessed the effects on adipocyte differentiation and maturation.
- Examined fat mass changes in vivo in mice models.
Main Results:
- Silencing ABCG1 effectively inhibited adipocyte differentiation and maturation.
- Reduced fat mass growth was observed in vivo following ABCG1 inhibition.
- Studies in obese subjects confirmed the detrimental role of ABCG1 in obesity.
Conclusions:
- Adipose tissue ABCG1 is a critical factor in obesity development.
- Targeting ABCG1 presents a potential therapeutic strategy for managing obesity.
- Further considerations regarding the feasibility and critical issues of this strategy are discussed.
More Related Videos
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
06:57Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice
Published on: November 11, 2021
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
01:24Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
01:24Obesity